RML Specialty Hospital

Abstract Introduction: Tuberculosis (TB) remains a major global health challenge, with over 10 million new cases and 1.5 million deaths annually. Despite significant declines in TB burden since 1990, disparities persist across regions and genders. Behavioral, metabolic, and socioeconomic factors exacerbate TB morbidity and mortality. This study analyzes global, regional, and national trends in TB incidence, mortality, and disability-adjusted life years 1990–202 using the Global Burden of Disease (GBD) database and projects future trends to 2040. Methods: Data from the GBD 2021 database were analyzed to evaluate TB incidence, deaths, and DALYs, per 100,000 population. Age, sex, and region-specific trends were examined, with stratification by Socio-Demographic Index (SDI) levels. Projections to 2040 were performed using ARIMA and ETS models. Statistical significance was assessed using t-tests and paired Wilcoxon tests. Results: In 2021, globally, the total number of cases and deaths of TB were estimated to be 4684699 and 725384 in Males and 3,722,433 and 437411 in females. From 1990-2021, global incidence, deaths, and DALYs rates declined consistently, with males experienced higher TB burden. Smoking and alcohol use for males and high fasting plasma glucose for females were the major contributors of death in TB. Low SDI regions, particularly Sub-Saharan Africa, recorded the higher TB burden, while high SDI regions achieved significant reductions. Projections to 2040 indicate further declines in TB incidence and mortality, narrowing gender disparities. Discussion: Global declines in TB metrics reflect advancements in public health policies, diagnostic tools, and treatment strategies. However, disparities persist, driven by socioeconomic determinants and risk factors. Strengthened interventions targeting poverty, comorbidities, and behavioral and metabolic risks are essential for high-burden regions. This study emphasizes the importance of integrated, region-specific strategies to accelerate global TB control and achieve sustainable reductions by 2040

A giant left atrium (GLA) is a challenging manifestation of advanced mitral valve disease, often necessitating mitral valve surgery via median sternotomy due to the anatomical distortion it causes. We present the case of a 50-year-old male patient with New York Heart Association (NYHA) class IV symptoms secondary to severe mitral regurgitation, found to have a left atrial diameter of 17.1 cm, to our knowledge, one of the largest ever reported. After declining sternotomy, the patient underwent successful minimally invasive mitral valve replacement. Despite significant anatomical challenges, the procedure was completed uneventfully through careful preoperative planning and specialized intraoperative techniques. While sternotomy remains standard in such complex presentations, advances in imaging, instrumentation, and surgical expertise are redefining procedural boundaries. This case demonstrates that minimally invasive mitral valve replacement can be safe, feasible, and effective even in patients with extreme atrial enlargement when performed by experienced teams.

Rationale: No systematic investigation into dyspnea in patients receiving prolonged ventilation (>21 d) after recovering from critical illness has been published. Objectives: We sought to determine the magnitude, nature, and pathophysiological basis of dyspnea during an unassisted-breathing trial in patients receiving prolonged ventilation. Methods: Dyspnea intensity and descriptor selection were investigated in 27 patients receiving prolonged ventilation during a 60-minute unassisted-breathing trial. Pressure-time product, respiratory mechanics, and PtcCO2 were also measured. Measurements and Main Results: Of 10 patients who reported dyspnea during assist-control ventilation, 9 (90.0%) selected "Not getting enough air" to characterize dyspnea. Vt setting was lower in dyspneic than in nondyspneic patients (480.0 vs. 559.4 ml), P < 0.046. During the unassisted-breathing trial (n = 26), patients developed increases in dyspnea (P < 0.01) and PtcCO2 (P < 0.01) but no change in [Formula: see text]e. Dyspnea score was strongly linked to PtcCO2 (P < 0.012) and airway resistance (P < 0.013) but not respiratory work (although pressure-time product was almost three times higher than normal). At 60 minutes into the trial, 83.3% of patients selected "Not getting enough air" on its own or in combination with "Too much effort" to describe discomfort, whereas only 16.7% selected "Too much effort" on its own (P < 0.001). Across the dyspnea spectrum, patients chose "Not getting enough air" overwhelmingly over other descriptor options (P < 0.001). Conclusions: Patients developed increases in dyspnea and PtcCO2 but unchanged [Formula: see text]e and work of breathing during an unassisted-breathing trial; patients selected air-hunger descriptors overwhelmingly over excessive effort. The observations support the belief that air hunger results from heightened respiratory center stimulation combined with the incapacity to increase [Formula: see text]e.

Introduction: Anaerobes are an important cause of infections but are often neglected. These infections can range from simple abscesses to life-threatening infections. The isolation of anaerobes is crucial for administering appropriate antibiotic therapy. Aim: To investigate the profile of anaerobes in various clinical samples, including deep-seated skin and tissue infections, aspirated body fluids, and tissue biopsies. Materials and Methods: A cross-sectional study was conducted on a total of 100 samples at the Department of Microbiology, ABVIMS and Dr RML Hospital, New Delhi, from November 2019 to March 2021. Aspirations from deep-seated abscesses, body fluids, intraoperative samples, and tissue biopsies meeting the criteria for anaerobic culture were included. Simultaneous processing for the detection of aerobes was also performed. Anoxomat III anaerobic culture system was used to create an anaerobic environment. Robertson Cooked Meat (RCM) broth was used, and subculture was conducted on 10% Blood Agar (BA). Presumptive identification was performed using gram stain, catalase test (15% hydrogen peroxide), metronidazole disc (5 µg), special potency disc (vancomycin 5 µg, kanamycin 1000 µg, colistin 10 µg), and aerotolerance test. The Vitek 2 compact ID system was used for the final identification of anaerobes. Statistical Package for Social Sciences (SPSS) software, IBM manufacturer, Chicago, USA, ver 21.0, was utilised. Results: The isolation rate of anaerobes was 17 (17%), with Bacteroides fragilis being the predominant organism (6; 35.29%), followed by Actinomyces (2; 11.76%), Clostridium (2; 11.76%), Peptostreptococcus (2; 11.76%), and Prevotella species (2; 11.76%). Isolation was observed from diverse anatomic sites, with pus aspirates constituting the majority of the isolates (9; 52.94%), followed by brain abscesses (3; 17.65%), liver abscesses, peritoneal fluid (2; 11.76%), and tonsillar abscess (1; 5.89%). Five (29.41%) infections were polymicrobial, while 12 (70.59%) were monomicrobial in nature. Conclusion: Anaerobes are emerging as an important causative agents in a variety of diverse and heterogeneous pyogenic infections. This study demonstrates their isolation from various infection sites. Therefore, routine anaerobic cultures should be conducted alongside aerobic cultures, and the importance of anaerobes in clinical infections should not be underestimated.

Introducción: Los cardiomiocitos poseen la maquinaria bioquímica capaz de sintetizar, utilizar y recapturar serotonina. Objetivo: Determinar si la miocardiopatía hipertrófica (MCH) induce cambios en la expresión de la triptófano-5-hidroxilasa (TPH) 1 y 2, el transportador de serotonina (SERT) y los receptores serotoninérgicos (RS). Métodos: Estudio transversal de cinco bloques de tejido de corazones con MCH y cinco bloques de corazones de control. Se obtuvieron cinco cortes de la pared libre del ventrículo izquierdo (PLVI) y del septum interventricular (SIV) de cada bloque, para determinar la expresión de TPH1 y TPH2, SERT y RS con anticuerpos por inmunofluorescencia. La inmunofluorescencia fue evaluada mediante t de WELCH, con nivel de significación de p < 0.05. Resultados: La PLVI y el SIV de los corazones con MCH mostraron aumento de la expresión de TPH1 y TPH2, así como de los receptores 5-HT2A y 5-HT2B en comparación con los controles (p < 0.01). El receptor 5-HT4 y SERT aumentaron en el SIV de los corazones con MCH (p < 0.01). Conclusiones: Se demostró aumento de las expresiones de TPH, SERT y RS en los cardiomiocitos de los corazones con MCH en comparación con los controles, lo cual podría participar en la fisiopatología de la MCH en los humanos.

&amp;lt;p&amp;gt;&amp;lt;a href="https://www.ajms.site/current/"&amp;gt;&amp;lt;strong&amp;gt;Blood Pressure Control and Antihypertensive Pharmacotherapy&amp;nbsp;Patterns in Hypertensive Cases in Erbil City&amp;lt;/strong&amp;gt;&amp;lt;/a&amp;gt;&amp;lt;br&amp;gt;\n&amp;lt;strong&amp;gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Dr. Mohammed Kawa Fathi &amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt;*, Dr. Mudhafar Abdulrahman Habeeb&amp;nbsp;&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;&amp;lt;/strong&amp;gt;&amp;lt;br&amp;gt;\n&amp;lt;sup&amp;gt;1. M.B.Ch.B., trainee at Kurdistan Higher Council of Medical Specialties- Cardiology, Surgical Specialty Hospital Cardiac Center&amp;ndash;Erbil&amp;lt;br&amp;gt;\n&amp;nbsp;2.M.B.Ch.B., PhD, FRCP; Assistant Professor of Cardiology-College of Medicine/ Hawler Medical University-Erbil&amp;lt;/sup&amp;gt;&amp;lt;/p&amp;gt;\n\n&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Background&amp;lt;/strong&amp;gt;:&amp;lt;br&amp;gt;\nHypertension is a common public health problem in Kurdistan region/Iraq. Different antihypertensive treatment agents and patterns are used aiming in blood pressure control, despite the advances in pharmacotherapies and increased awareness, blood pressure control is still unsatisfactory.&amp;lt;br&amp;gt;\n&amp;lt;strong&amp;gt;Aim of study:&amp;lt;/strong&amp;gt;&amp;lt;br&amp;gt;\nTo determine the rate of blood pressure control in hypertensive patients on medications, concentrating on pharmacological patterns along with determining the importance of compliance.&amp;lt;br&amp;gt;\n&amp;lt;strong&amp;gt;Patients &amp;amp;methods:&amp;lt;/strong&amp;gt;&amp;lt;br&amp;gt;\nAn observational cross sectional study conducted in Outpatient Clinics in Erbil city-Kurdistan region/Iraq through duration period of six months from January to 30&amp;lt;sup&amp;gt;th&amp;lt;/sup&amp;gt; of June 2022 on a sample of two hundred and thirty known hypertensive adult patients was selected after eligibility to inclusion exclusion criteria. The diagnosis of hypertension was done by physician according to and international guidelines. The controlled blood pressure was defined when it is less than 140/90mmHg and for patients&amp;nbsp;with type 2 diabetes mellitus the target is less than 130/80mmhg.&amp;lt;br&amp;gt;\n&amp;lt;strong&amp;gt;Results:&amp;lt;/strong&amp;gt;&amp;lt;br&amp;gt;\nAmong hypertensive patients, 56.1% had controlled and 43.9% had uncontrolled hypertension. The common antihypertensive pharmacotherapy used were angiotensin receptor blockers (51.3%) and calcium channel blockers(51.3%); followed by diuretics beta-blockers (32.2%). The mean blood pressure of hypertensive patients was (138.9/81&amp;nbsp;mmHg); was a significant association between calcium channel blockers use and controlled pressure (p=0.03).A significant association was observed between fixed combination treatment and controlled blood pressure (p=0.008).&amp;lt;br&amp;gt;\n&amp;lt;strong&amp;gt;Conclusions:&amp;nbsp;&amp;lt;/strong&amp;gt;&amp;lt;br&amp;gt;\nIn our study, more than half of have their BP controlled and the blood&amp;nbsp;pressure control was better in patients taking channel blockers with fixed-dose combination&amp;lt;/p&amp;gt;

Hypospadias is among the most prevalent urogenital malformations in male newborns. It is characterized by the displacement of the urethral meatus to the ventral side of the penis, an aberrant ventral curve of the penis referred to as "chordee," and an abnormally arranged foreskin with a "hood" found dorsally and lacking foreskin ventrally. Patients may have an extra genitourinary abnormality based on the area of the lesion. In around 70% of cases, the urethral meatus is positioned distally to the shaft, representing a milder form of the disease. The remaining 30% of cases are located proximally, are more complicated, and require further evaluation. Although the origin of hypospadias is mostly obscure, several suggestions exist about genetic susceptibility and hormonal factors. The objective of hypospadias restoration is to restore aesthetic and functional regularity, and surgery is currently advised at a young age, mostly between six and 18 months. At any age, hypospadias can be repaired with an equivalent risk of complications, functional outcomes, and aesthetic outcomes. However, the best age of treatment is still undetermined. Even though the long-term effects on appearance and sexual function are usually good, males may be less likely to make the first move after rectification. Also, people who have hypospadias treated are twice as likely to have problems with their lower urinary tract. These problems can last for years after the initial repair.

BackgroundPatterns of shedding replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in severe or critical COVID-19 are not well characterized. We investigated the duration of replication-competent SARS-CoV-2 shedding in upper and lower airway specimens from patients with severe or critical coronavirus disease 2019 (COVID-19).MethodsWe enrolled patients with active or recent severe or critical COVID-19 who were admitted to a tertiary care hospital intensive care unit (ICU) or long-term acute care hospital (LTACH) because of COVID-19. Respiratory specimens were collected at predefined intervals and tested for SARS-CoV-2 using viral culture and reverse transcription–quantitative polymerase chain reaction (RT-qPCR). Clinical and epidemiologic metadata were reviewed.ResultsWe collected 529 respiratory specimens from 78 patients. Replication-competent virus was detected in 4 of 11 (36.3%) immunocompromised patients up to 45 days after symptom onset and in 1 of 67 (1.5%) immunocompetent patients 10 days after symptom onset (P = .001). All culture-positive patients were in the ICU cohort and had persistent or recurrent symptoms of COVID-19. Median time from symptom onset to first specimen collection was 15 days (range, 6–45) for ICU patients and 58.5 days (range, 34–139) for LTACH patients. SARS-CoV-2 RNA was detected in 40 of 50 (80%) ICU patients and 7 of 28 (25%) LTACH patients.ConclusionsImmunocompromise and persistent or recurrent symptoms were associated with shedding of replication-competent SARS-CoV-2, supporting the need for improving respiratory symptoms in addition to time as criteria for discontinuation of transmission-based precautions. Our results suggest that the period of potential infectiousness among immunocompetent patients with severe or critical COVID-19 may be similar to that reported for patients with milder disease.